Eli Lilly’s Jaypirca Triplet Therapy Shatters Expectations in Phase 3 CLL Trial 2 min read Industries Eli Lilly’s Jaypirca Triplet Therapy Shatters Expectations in Phase 3 CLL Trial Pharm'Up Eli Lilly and Company has announced a major therapeutic milestone in the treatment of B-cell malignancies. The... Read More Read more about Eli Lilly’s Jaypirca Triplet Therapy Shatters Expectations in Phase 3 CLL Trial
Pharm'Up 
